Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Development

Phase 3 Trials

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

The interim finding shows the vaccine plus Keytruda reduced recurrence and distant spread in high‑risk, resected melanoma and could prompt regulator talks once full data are released.

6 ARTICLES

2mo ago

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

22 ARTICLES

2mo ago

Eli Lilly Agrees to Buy Psychedelic Biotech AtaiBeckley for $2.8 Billion

35 ARTICLES

4mo ago

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

13 ARTICLES

5mo ago

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

5 ARTICLES

5mo ago

EMA Validates Astellas Bid to Add Padcev–Keytruda Combo for Perioperative Muscle-Invasive Bladder Cancer

9 ARTICLES

5mo ago

Kailera Leaps 62% in Nasdaq Debut After $625 Million IPO

8 ARTICLES

9mo ago

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

3 ARTICLES

11mo ago

J&J Myeloma Trial Stopped Early After Tecvayli–Darzalex Shows PFS and OS Benefit

6 ARTICLES

11mo ago

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials